ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1011

Correlations Between B Cell Epitope Specificity and Clinical Features in Patients with Jo-1 Antibodies and the Anti-Synthetase Syndrome

Joseph LaConti1, Fanny Kippelen2, Rohit Aggarwal3 and Dana P. Ascherman4, 1Division of Rheumatology, University of Miami Miller School of Medicine, Miami, FL, 2Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 3Department of Medicine / Rheumtology, University of Pittsburgh Medical Center, Pittsburgh, PA, 4Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Antibodies, myositis and synthetase syndrome

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, November 13, 2016

Session Title: Muscle Biology, Myositis and Myopathies

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Correlations Between B Cell Epitope Specificity and Clinical Features in Patients with Jo-1 Antibodies and the Anti-Synthetase Syndrome

Background/Purpose: Idiopathic inflammatory myopathy (IIM) is an autoimmune disorder characterized by muscular as well as extra-muscular organ pathology.  The anti-synthetase syndrome is specifically associated with auto-antibodies directed against amino-acyl-tRNA synthetases and encompasses a clinical spectrum comprised of myositis, interstitial lung disease, Raynauds’s phenomenon, symmetric non-erosive arthritis, mechanic’s hands, and fever.  The most common autoantibody is anti-Jo-1 which targets histidyl-tRNA synthetase (HRS).  Previous work assessing the reactivity of serum anti-Jo-1 antibodies with full length recombinant HRS demonstrated cross-sectional as well as longitudinal correlations with serum creatinine kinase levels, myositis visual analogue scale (VAS), arthritis VAS, and different components of the Myositis Intention to Treat Activity Index (MITAX).  In the current study, we aimed to refine these correlations through more detailed assessment of the relationship between HRS epitope specificity and clinical features of the anti-synthetase syndrome. 

Methods: We assessed serum reactivity (via ELISA) against overlapping sub-fragments of HRS/Jo-1 protein (Fig 1) in 139 patients with anti-Jo-1 antibodies and different patterns of organ involvement.  Use of Mann U Whitney and Kruskal Wallace testing permitted statistical correlations of epitope specificity with various clinical features encompassed by the Myositis Disease Activity Assessment Tool (MDAAT). 

Results: Our results indicate that defined clinical features such as joint swelling and Raynaud’s are associated with enhanced antibody binding of amino-terminal HRS sub-fragments—with a trend toward preferential antibody affinity for sub-fragments containing amino acids 90-150 (A3-A5).  While reactivity to A3-A5 generally overlapped in different patient subsets, reactivity to A2 (aa 1-60) was frequently lower than that of larger subfragments encompassed by A3-A5.  Patients with joint swelling had significantly increased reactivity to fragments A2 (p = 0.0036), A3 (p = 0.0015), A4 (p = 0.0014) and A5 (p = 0.0016) relative to patients without joint swelling.  Patients with Raynaud’s also had significantly increased reactivity to fragments A2 (p = 0.0147), A3 (p = 0.0497), A4 (p = 0.0209) and A5 (p = 0.0225) compared to patients without Raynaud’s.

Conclusion: This work not only confirms that the amino terminal portion of HRS/Jo-1 contains an immunodominant B cell epitope, but also suggests that fine specificity mapping may provide useful biomarkers for different patterns and/or severity of organ involvement.  More broadly, these results support the possibility that tissue-specific alterations in antigen presentation are linked to disease pathogenesis.  


Disclosure: J. LaConti, None; F. Kippelen, None; R. Aggarwal, None; D. P. Ascherman, None.

To cite this abstract in AMA style:

LaConti J, Kippelen F, Aggarwal R, Ascherman DP. Correlations Between B Cell Epitope Specificity and Clinical Features in Patients with Jo-1 Antibodies and the Anti-Synthetase Syndrome [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/correlations-between-b-cell-epitope-specificity-and-clinical-features-in-patients-with-jo-1-antibodies-and-the-anti-synthetase-syndrome/. Accessed January 22, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlations-between-b-cell-epitope-specificity-and-clinical-features-in-patients-with-jo-1-antibodies-and-the-anti-synthetase-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.